Fouad Namouni, PRESIDENT, R & D at Blueprint Medicines Corp (BPMC), sold 6,954 shares at $67.30 ($468K) on 2022-10-04, disclosed to the SEC on 2022-10-05.
Open-market sale of $468k BPMC by PRESIDENT, R & D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.30 | 3,477 | $234K | 50.0% |
| 2 | $67.30 | 3,477 | $234K | 50.0% |
| Total | $67.30 avg | 6,954 | $468K | 100% |
| Filing → |
| BPMC | SELL | 2024-03-11 | $794K | — | Filing → |
| BPMC | SELL | 2023-10-05 | $362K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $175K | — | Filing → |